CLEVELAND — According to the American Cancer Society, more than 82,000 people will be diagnosed with bladder cancer this year. Less than twenty thousand will be women. Bladder cancer is typically a ...

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...

DEAR MAYO CLINIC: I'm 80 years old and have a prolapsed bladder. I'm using a pessary, but I'd like to have my bladder repaired instead. What is the least invasive option? Even at an advanced age, ...

Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...

Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...

Perioperative management for muscle invasive bladder cancer (MIBC) includes neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy and risk-adapted adjuvant immunotherapy. More ...

Doctors consider surgery for interstitial cystitis (IC) as a last resort when other treatments, such as diet changes, medications, bladder instillations, and physical therapy, have failed to bring ...

Bladder cancer is mainly urothelial carcinoma, with non-muscle-invasive and muscle-invasive types, and smoking as a key risk factor. Diagnosis involves cystoscopy, biopsy, urine cytology, and imaging ...

BERLIN—Radiotherapy is a viable alternative to surgery for invasive bladder cancer, according to a study presented at the joint congress of the European Cancer Organization and European Society for ...

If you're among the millions of women suffering from interstitial cystitis, a bladder disorder characterized by intense discomfort, you may have struggled for years to find the right treatment. For ...

Ferring Pharmaceuticals and Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) are pleased to announce that they have ...